<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="study was performed to evaluate the clinical course of the" exact="infection" post="in 168 patients with autoimmune inflammatory disease using biological"/>
 <result pre="using bDMARDs and to verify the frequency of asymptomatic CHIKV" exact="infection" post="compared with that of healthy household contacts. 2. Materials"/>
 <result pre="For the comparison group (control), we selected people with no" exact="diagnosis" post="of inflammatory disease or use of immunosuppressants who lived"/>
 <result pre="controls to collect clinical information about suggestive symptoms of CHIKV" exact="infection" post="between December 2016 and May 2017, the period of"/>
 <result pre="inflammatory arthropathy and using bDMARDs, 94 (56%) subjects had a" exact="diagnosis" post="of rheumatoid arthritis, and the most frequent class of"/>
 <result pre="3.2. Symptoms of CHIKV and Seropositivity Suggestive symptoms of CHIKV" exact="infection" post="were reported by 51/168 (30%) of the patients in"/>
 <result pre="use of anti-TNF biologicals, and a larger number of asymptomatic" exact="infection" post="cases, although without statistical significance. A few published studies"/>
 <result pre="studies in the literature refer to the pattern of CHIKV" exact="infection" post="in biological users and do not show a more"/>
 <result pre="of Rheumatology for patients using bDMARDs with clinical-epidemiological or laboratory" exact="diagnosis" post="of arbovirus infection is to suspend biological therapy until"/>
 <result pre="patients using bDMARDs with clinical-epidemiological or laboratory diagnosis of arbovirus" exact="infection" post="is to suspend biological therapy until recovery from the"/>
 <result pre="the significant difference in the number of cases with subclinical" exact="infection" post="between the two groups. 5. Conclusion In patients with"/>
 <result pre="ColombiaF1000Research20165p. 36010.12688/f1000research.8235.2 4BonifayT.PrinceC.NeyraC.et al.Atypical and severe manifestations of chikungunya virus" exact="infection" post="in French Guiana: a hospital-based studyPLoS One2018131210.1371/journal.pone.0207406 5Antunes de"/>
 <result pre="and Infection2009137453454110.1017/S095026880800116718694529 7RenaultP.de ValkH.BalleydierE.et al.A major epidemic of chikungunya virus" exact="infection" post="on rÃ©union island, France, 2005-2006The American Journal of Tropical"/>
 <result pre="Journal of Tropical Medicine and Hygiene200777472773110.4269/ajtmh.2007.77.72717978079 8RutherfordA. I.SubesingheS.HyrichK. L.GallowayJ. B.Serious" exact="infection" post="across biologic-treated patients with rheumatoid arthritis: results from the"/>
 <result pre="an updateExpert Review of Gastroenterology &amp;amp; Hepatology201812111101110810.1080/17474124.2018.153098330277409 11AtrasheuskayaA.PetzelbauerP.FredekingT. M.IgnatyevG.Anti-TNF antibody" exact="treatment" post="reduces mortality in experimental dengue virus infectionFEMS Immunology &amp;amp;"/>
 <result pre="serologic diagnostic tests for chikungunya virusEmerging Infectious Diseases201420122129213210.3201/eid2012.14126925418184 15RosarioV.Munoz-LouisR.ValdezT.et al.Chikungunya" exact="infection" post="in the general population and in patients with rheumatoid"/>
 <result pre="with rheumatoid arthritis on biological therapyClinical Rheumatology20153471285128710.1007/s10067-015-2979-x26017232 16BrunierL.PolomatK.DelignyC.et al.Chikungunya virus" exact="infection" post="in patients on biotherapiesJoint Bone Spine201683224524610.1016/j.jbspin.2015.08.00426603267 17AssunÃ§Ã£o-MirandaI.Cruz-OliveiraC.Da PoianA. T.Molecular"/>
 <result pre="Diseases201711110.1371/journal.pntd.0005319 21MarquesC.DuarteA.RanzolinA.et al.Recommendations of the Brazilian society of rheumatology for" exact="diagnosis" post="and treatment of chikungunya fever. Part 1â€&quot;diagnosis and special"/>
 <result pre="al.Recommendations of the Brazilian society of rheumatology for diagnosis and" exact="treatment" post="of chikungunya fever. Part 1â€&quot;diagnosis and special situationsRevista Brasileira"/>
 <result pre="necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza" exact="infection" post="in miceCritical Care2013176p. R30110.1186/cc13171 Table 1 Clinical and demographic"/>
</results>
